title: Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease.
abstract: OBJECTIVE
  Because Helicobacter pylori is a potentially dangerous human pathogen, the protective potential of oral immunization with H. pylori urease and its subunits was evaluated in an animal model.
  
  
  METHODS
  Mice were orally immunized with H. pylori sonicate, urease, or recombinant enzymatically inactive urease subunits and then challenged with Helicobacter felis. Control mice were sham-immunized.
  
  
  RESULTS
  H. felis colonization was present 5 days after challenge in 9 of 10 sham-immunized, 6 of 9 sonicate-immunized, and 3 of 10 urease-immunized animals (P = 0.031 vs. sham-immunized). Twelve days after challenge, urease B-immunized mice had a weaker colonization than sham-immunized controls, whereas urease A had no effect. After 70 days, most urease A- and urease B-immunized mice had cleared the colonization (10/17: P = 0.0019; 16/20: P = 0.00002 vs. sham-immunized). In urease B-immunized animals, protection was often associated with corpus gastritis.
  
  
  CONCLUSIONS
  Oral immunization with H. pylori urease protects mice against H. felis infection. Enzymatically inactive urease A and B subunits contain protective epitopes. It is unclear whether protection depends on the development of a mononuclear inflammatory response in the gastric corpus. Our observations should encourage the development of a human vaccine.
authors.affiliation: Division of Gastroenterology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
authors.forename: P
authors.initials: P
authors.lastname: Michetti
authors.forename: I
authors.initials: I
authors.lastname: Corthésy-Theulaz
authors.forename: C
authors.initials: C
authors.lastname: Davin
authors.forename: R
authors.initials: R
authors.lastname: Haas
authors.forename: A C
authors.initials: AC
authors.lastname: Vaney
authors.forename: M
authors.initials: M
authors.lastname: Heitz
authors.forename: J
authors.initials: J
authors.lastname: Bille
authors.forename: J P
authors.initials: JP
authors.lastname: Kraehenbuhl
authors.forename: E
authors.initials: E
authors.lastname: Saraga
authors.forename: A L
authors.initials: AL
authors.lastname: Blum
mesh_terms: D000284:Administration, Oral; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D003429:Cross Reactions; D005260:Female; D005756:Gastritis / Q000473:pathology; D016481:Helicobacter Infections / Q000517:prevention & control*; D016480:Helicobacter pylori / Q000201:enzymology*; D007114:Immunization; D051379:Mice; D008807:Mice, Inbred BALB C; D011994:Recombinant Proteins; D013270:Stomach / Q000473:pathology; D014510:Urease / Q000008:administration & dosage / Q000145:classification / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D011994:Recombinant Proteins; D014510:Urease